Abinash Choudhury: A Mother’s Advocacy Transforming Hemophilia Care in Nigeria
Abinash Choudhury, Associate Scientific Writer at Sanofi Global Hub, shared on LinkedIn:
”In Nigeria, undiagnosed bleeding disorders have historically led to deaths that went unrecorded.
For Megan Adediran Founder and Executive Director, Haemophilia Foundation of Nigeria, that reality became personal when her sons were diagnosed with Hemophilia A and the resources simply were not there.
So, she built them.
‘The love of a mother was my only motivation. I just wanted my son[s] to live.’
‘What started as a mother’s fight became the Haemophilia Foundation of Nigeria, directly confronting the systemic barriers that leave so many without access to diagnosis or care.’
This World Hemophilia Day, Megan‘s story reminds us why this year’s theme, ‘Diagnosis, first step to care,’ is a challenge to everyone working across health systems, policy, and advocacy to close the gaps that still exist.
We are proud to partner with the World Federation of Hemophilia to advance equitable, sustainable access to care for people with hemophilia globally.
See how we are working to make that a reality.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion
-
Sep 3, 2026, 10:31Alan Nurden: Comparing Antiplatelet and Antithrombin Therapies in Coronary Microcirculation
-
Sep 3, 2026, 08:53Jamie’s Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association
-
Sep 3, 2026, 08:00Beth Meneley: When Transfusion Is Not an Option – HBOT for Exceptional Blood Loss Anemia
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease